Results 11 to 20 of about 23,005 (222)

Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analyses

open access: yesFrontiers in Pharmacology, 2013
Antagonism of N-methyl-D-aspartate (NMDA) receptors by phencyclidine is thought to underlie its ability to induce a schizophrenia-like syndrome in humans, yet evidence indicates it has a broader pharmacological profile.
Wendy K Adams   +3 more
doaj   +2 more sources

Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the generalized singular value decomposition [PDF]

open access: yes, 2011
The quantification of experimentally-induced alterations in biological pathways remains a major challenge in systems biology. One example of this is the quantitative characterization of alterations in defined, established metabolic pathways from complex ...
Dawson, Neil   +24 more
core   +6 more sources

Phencyclidine disposition and reversal of toxicity by monoclonal antibody.

open access: yes, 1989
A physiologic model for phencyclidine disposition in the rat was established. This model was able to accurately predict phencyclidine disposition in most rat tissues.
Bozigian, Haig Philip.
core   +5 more sources

Phenotypical Screening on Neuronal Plasticity in Hippocampal-Prefrontal Cortex Connectivity Reveals an Antipsychotic with a Novel Profile

open access: yesCells, 2022
Dysfunction in the hippocampus-prefrontal cortex (H-PFC) circuit is a critical determinant of schizophrenia. Screening of pyridazinone-risperidone hybrids on this circuit revealed EGIS 11150 (S 36549). EGIS 11150 induced theta rhythm in hippocampal slice
Michael Spedding   +18 more
doaj   +1 more source

P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia

open access: yesFrontiers in Molecular Neuroscience, 2020
Background: It has been consistently reported that the deficiency of the adenosine triphosphate (ATP) sensitive purinergic receptor P2X7 (P2X7R) ameliorates symptoms in animal models of brain diseases.Objective: This study aimed to investigate the role ...
Stefano Calovi   +14 more
doaj   +1 more source

Phencyclidine-induced behavioral sensitization [PDF]

open access: yes, 1994
Chronic administration of a psychomotor stimulant has been shown to produce progressively enhanced effects, a phenomenon called "reverse tolerance" or sensitization.
Xu, Xiaojuan, Domino, Edward F.
core   +1 more source

Phencyclidine-induced changes in rat cortical gene expression identified by microarray analysis: implications for schizophrenia

open access: yesNeurobiology of Disease, 2004
Acute phencyclidine induces schizophrenia-like symptoms in healthy humans and psychotic episodes in schizophrenics. Although phencyclidine is known as a N-methyl d-aspartate receptor antagonist (NMDA-R), the molecular events underlying the behavioral ...
Sergio Kaiser   +7 more
doaj   +1 more source

The suitability of zebrafish (danio rerio) as an optimal organism to further investigate the associated schizophrenia-like phenotype

open access: yesEuropean Psychiatry, 2023
Introduction Zebrafish (Danio rerio) has evolved over the years as a preferred organism due to its vast repertoire in research fields that mimic a targeted phenotype, particularly behavioral typologies and specific attributes comparable to murine models
I. B. Nita   +5 more
doaj   +1 more source

Increased Cortical Nitric Oxide Release After Phencyclidine Administration [PDF]

open access: yes, 2009
Phencyclidine exerts psychotomimetic effects in humans and is used as a pharmacological animal model for schizophrenia. We, and others, have demonstrated that phencyclidine induces cognitive deficits in rats that are associated with schizophrenia ...
Svensson, Lennart   +13 more
core   +1 more source

Pridopidine Reverses Phencyclidine-Induced Memory Impairment

open access: yesFrontiers in Pharmacology, 2018
Pridopidine is in clinical trials for Huntington's disease treatment. Originally developed as a dopamine D2 receptor (D2R) ligand, pridopidine displays about 100-fold higher affinity for the sigma-1 receptor (sigma-1R).
Kristoffer Sahlholm   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy